Cytiva
June 16, 2025
Company Presentation
Platform for Therapeutics
Cytiva exists to help our customers advance and accelerate therapeutics. Researchers, academia, and biopharma undertake life-saving activities ranging from biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. We supply them with the tools and services they need to work better, faster, and safer, leading to better patient outcomes. And we bring a breadth and depth of expertise, solutions and services across the stages of a therapeutic’s journey to commercialization to help our customers every step of the way.
Company HQ City:
Marlborough
Company HQ State:
MA
Company HQ Country:
United States
Year Founded:
2020 (following acquisition)
Lead Product in Development:
Multiple
CEO
Chris Riley
Development Phase of Lead Product
Other/Not Applicable
Exchange
This information is relevant to our parent company, DHR and we no not supply this information at the Cytiva level
Ticker
DHR
When you expect your next catalyst update?
This information is relevant to our parent company, DHR and we no not supply this information at the Cytiva level
What is your next catalyst (value inflection) update?
This information is relevant to our parent company, DHR and we no not supply this information at the Cytiva level
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}